Alli M. Straubhar

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Metastatic renal cell carcinoma with sarcomatoid histology (SmRCC) is associated with poor survival. No data is available from randomized trials on the efficacy of vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) inhibitors in SmRCC. We identified SmRCC patients from a single institutional database. To identify predictive(More)
  • 1